| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > PR > Celebrities Can't Have It Both Ways |
|
Just Other Articles - Celebrities Can't Have It Both Ways
Corporations are willing to pay substantial amounts of money to prominent
personalities so that consumers will relate the brand with their favorite star,
and thus will be more According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product likely to buy the product. The buying public imparts
credibility to the celebrity because of his or her charisma as well as the
credibility that comes with prominence in the ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in media. The power of someone's
personality also entails risks for the brand with which they are associated,
because any controversial behavior may reflect badly on the product lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. . This has
become an especially frequent problem in recent times. Whoopi Goldberg, for example, lost her Slim Fast contract due to her abrasive remarks regarding the Presiden here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe t. The people at Slim Fast did not want their
brand associated with a personality embroiled in controversy, who was likely to
upset people by insulting a respected figure. In d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro 1989, Pepsi dropped Madonna
for her "sacrilegious" "Like a Prayer" video. McDonald's allowed Kobe Bryant's
contract with them to lapse after a woman accused him of rape. After ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc allegedly
entering a special treatment program for anorexia, Mary-Kate Olsen vanished
from the "Got Milk?" campaign. Hip-hop star Ludacris became another Pepsi
casualty whe easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi n executives heard Bill O'Reilly remark upon the obscenity of the
rapper's lyrics, and decided he wasn't beneficial for their soda's reputation. Sometimes celebrities act indig nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically nant when they lose an endorsement due to
remarks they made or other forms of expression in which they indulged, as if
their freedom of speech has been violated. Whoopi Goldbe and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ rg felt she was being
"punished" for speaking freely. The First Amendment says nothing about
having an inherent right to multi-million dollar deals, just that the State cannot ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
prosecute you for the content of your expression. On the other hand, if the
State were to dictate Slim Fast's ad campaign by forcing them to retain
Goldberg, that would be a ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a violation of Slim Fast's rights. For many years, celebrities like Whoopi have made enviable amounts of money from endorsements, but now that they are getting axed so frequentl dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod y, they
may need to take caution if they want to keep this source of revenue.
Celebrities are not so irreplaceable and unique. Companies fed up with
prominent scandals can e cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin asily resort to lesser-known actors who have not
accumulated a reputation, bad or otherwise. Advertisers can even employ
animated or animal mascots, who have absolutely no ind tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ependent life of their
own, and thus will not ever bring shame upon the company name. Thus,
household names who lose their reputation may also lose their big advertising
mon t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel ey to, let's say, Tony the Tiger. This phenomenon brings to mind what
Cassius said in Shakespeare's Othello, "O, I have lost my reputation!... and what
remains is bestial." S ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust uperstars have to make a choice when it comes to endorsements. They have
to realize that companies have reasons for keeping them, and for getting rid of
them. If celebrities w y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ant to do as they please, they cannot expect companies to
put up with everything they do and keep on paying them. Eminem lives by his
own rules, and companies never hire him f . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de or endorsements; but he doesn't
seem to care. Those who care about the exposure and money associated with
endorsement deals must cultivate a good reputation, maintaining healt elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip hy,
controversy-free public personas. Otherwise, we will keep seeing more and
more stars disappearing from the ad campaigns in which we have become
accustomed to seeing them tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Job Hunting Tips -- Writing The Perfect CV -- Part 2 Make Your Own History During Women's History Month
|